Kerbel RS - Search Results

1

ErbB2/Her2-dependent downregulation of a cell death-promoting protein BLNK in breast cancer cells is required for 3D breast tumor growth.

Liu X, Chipurupalli S, Jiang P, Tavasoli M, Yoo BH, McPhee M, Mazinani S, Francia G, Kerbel RS, Rosen KV. Liu X, et al. Among authors: kerbel rs. Cell Death Dis. 2022 Aug 6;13(8):687. doi: 10.1038/s41419-022-05117-9. Cell Death Dis. 2022. PMID: 35933456 Free PMC article.

2

Induction and reversal of cell adhesion-dependent multicellular drug resistance in solid breast tumors.

Kerbel RS, St Croix B, Florenes VA, Rak J. Kerbel RS, et al. Hum Cell. 1996 Dec;9(4):257-64. Hum Cell. 1996. PMID: 9183656 Review.

3

Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors.

Petit AM, Rak J, Hung MC, Rockwell P, Goldstein N, Fendly B, Kerbel RS. Petit AM, et al. Among authors: kerbel rs. Am J Pathol. 1997 Dec;151(6):1523-30. Am J Pathol. 1997. PMID: 9403702 Free PMC article.

4

Downregulation of the pro-apoptotic protein Bak is required for the ras-induced transformation of intestinal epithelial cells.

Rosen K, Rak J, Jin J, Kerbel RS, Newman MJ, Filmus J. Rosen K, et al. Among authors: kerbel rs. Curr Biol. 1998 Dec 3;8(24):1331-4. doi: 10.1016/s0960-9822(07)00564-7. Curr Biol. 1998. PMID: 9843689 Free article.

5

Activated Ras prevents downregulation of Bcl-X(L) triggered by detachment from the extracellular matrix. A mechanism of Ras-induced resistance to anoikis in intestinal epithelial cells.

Rosen K, Rak J, Leung T, Dean NM, Kerbel RS, Filmus J. Rosen K, et al. Among authors: kerbel rs. J Cell Biol. 2000 Apr 17;149(2):447-56. doi: 10.1083/jcb.149.2.447. J Cell Biol. 2000. PMID: 10769035 Free PMC article.

6

Induction of anoikis and suppression of human ovarian tumor growth in vivo by down-regulation of Bcl-X(L).

Frankel A, Rosen K, Filmus J, Kerbel RS. Frankel A, et al. Among authors: kerbel rs. Cancer Res. 2001 Jun 15;61(12):4837-41. Cancer Res. 2001. PMID: 11406560

7

Antitumor effects in mice of low-dose (metronomic) cyclophosphamide administered continuously through the drinking water.

Man S, Bocci G, Francia G, Green SK, Jothy S, Hanahan D, Bohlen P, Hicklin DJ, Bergers G, Kerbel RS. Man S, et al. Among authors: kerbel rs. Cancer Res. 2002 May 15;62(10):2731-5. Cancer Res. 2002. PMID: 12019144

8

Thrombospondin 1, a mediator of the antiangiogenic effects of low-dose metronomic chemotherapy.

Bocci G, Francia G, Man S, Lawler J, Kerbel RS. Bocci G, et al. Among authors: kerbel rs. Proc Natl Acad Sci U S A. 2003 Oct 28;100(22):12917-22. doi: 10.1073/pnas.2135406100. Epub 2003 Oct 15. Proc Natl Acad Sci U S A. 2003. PMID: 14561896 Free PMC article.

9

Antiadhesive antibodies targeting E-cadherin sensitize multicellular tumor spheroids to chemotherapy in vitro.

Green SK, Francia G, Isidoro C, Kerbel RS. Green SK, et al. Among authors: kerbel rs. Mol Cancer Ther. 2004 Feb;3(2):149-59. Mol Cancer Ther. 2004. PMID: 14985455

10

A comparative analysis of low-dose metronomic cyclophosphamide reveals absent or low-grade toxicity on tissues highly sensitive to the toxic effects of maximum tolerated dose regimens.

Emmenegger U, Man S, Shaked Y, Francia G, Wong JW, Hicklin DJ, Kerbel RS. Emmenegger U, et al. Among authors: kerbel rs. Cancer Res. 2004 Jun 1;64(11):3994-4000. doi: 10.1158/0008-5472.CAN-04-0580. Cancer Res. 2004. PMID: 15173013

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

421 results

Search Page

Filters